×

Message

EU e-Privacy Directive

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

View e-Privacy Directive Documents

You have declined cookies. This decision can be reversed.

Electrophoretic analysis of the low molecular weight RNA and quantitative determination of the absolute level of miRNAs in samples of biological fluids

Search of diagnostic and prognostic markers of a number of serious human diseases, including myocardial ischemic injury, is an important and urgent problem of applied molecular biology. The need of the improvement of myocardial protection techniques and approaches that can predict the course of the patient recovery after surgery makes it particularly important to find new highly specific and sensitive biomarkers of earliest stages of cardiomyocytes damage. MicroRNAs are the possible candidates for the role of such biomarkers due to tissue-specific expression, rapid changes in levels and presence in circulation in the form stable to degradation.

Research work is aimed to reveal dynamics of circulating microRNAs in animal models of myocardial ischemia and in patients plasma during coronary artery bypass grafting surgery, detection of intracellular and extracellular miRNA partners, as well as the development of methods to overcome PCR inhibition in heparinized samples and protocols for rapid assessment of ischemic myocardial injury by measuring the absolute levels of circulating microRNAs.

REGISTERED: Handelsregister Schwyz
COMPANY NUMBER: CH-1029-379-06
TAX NUMBER: 1029-379-06
Copyright © 2017. All Rights Reserved.
Institute for Biomodulation Medicine AG

SCHWERZISTRASSE 4, CH-8807 FREIENBACH (SZ)
PHONE: +41 41 5003753 FAX: +41 41 5003754
EMAIL: INFO@BIOMODULATION.ORG

logo

INSTITUTE FOR BIOMODULATION
MEDICINE

0.png0.png4.png5.png9.png7.png1.png4.png
Today6
Yesterday472
This week478
This month8340
Total459714

Tuesday, 19 February 2019 00:18